205 related articles for article (PubMed ID: 8831774)
1. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
2. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of novel calpain inhibitors in preventing renal cell death.
Harriman JF; Waters-Williams S; Chu DL; Powers JC; Schnellmann RG
J Pharmacol Exp Ther; 2000 Sep; 294(3):1083-7. PubMed ID: 10945863
[TBL] [Abstract][Full Text] [Related]
4. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
5. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.
Ovat A; Li ZZ; Hampton CY; Asress SA; Fernández FM; Glass JD; Powers JC
J Med Chem; 2010 Sep; 53(17):6326-36. PubMed ID: 20690647
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
[TBL] [Abstract][Full Text] [Related]
9. A novel series of urea-based peptidomimetic calpain inhibitors.
Sanders ML; Donkor IO
Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
[TBL] [Abstract][Full Text] [Related]
10. An enormously active and selective azapeptide inhibitor of cathepsin B.
Wieczerzak E; Rodziewicz-Motowidło S; Jankowska E; Giełdoń A; Ciarkowski J
J Pept Sci; 2007 Aug; 13(8):536-43. PubMed ID: 17617796
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
Donkor IO; Korukonda R; Huang TL; LeCour L
Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors.
Lubisch W; Hofmann HP; Treiber HJ; Möller A
Bioorg Med Chem Lett; 2000 Oct; 10(19):2187-91. PubMed ID: 11012026
[TBL] [Abstract][Full Text] [Related]
14. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
[TBL] [Abstract][Full Text] [Related]
16. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel alpha-ketoamides incorporating polar residues at the P1'-position.
Donkor IO; Han J; Zheng X
J Med Chem; 2004 Jan; 47(1):72-9. PubMed ID: 14695821
[TBL] [Abstract][Full Text] [Related]
18. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
Xing R; Hanzlik RP
J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
[TBL] [Abstract][Full Text] [Related]
19. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
Crawford C; Mason RW; Wikstrom P; Shaw E
Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
[TBL] [Abstract][Full Text] [Related]
20. New m-calpain substrate-based azapeptide inhibitors.
Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
